Increased vascular endothelial growth factor 165 binding to kinase insert domain-containing receptor after infection of human endothelial cells by recombinant adenovirus encoding the Vegf165 gene

Circulation

Volumn 103, Issue 14, 2001, Pages 1887-1892

  Weisz, Anat ^a,b,c   Koren, Belly ^a,b,c   Cohen, Tzafra ^a,b,c   Neufeld, Gera ^a,b,c   Kleinberger, Tamar ^a,b,c   Lewis, Basil S ^a,b,c   Flugelman, Moshe Y ^a,b,c  

^a CARMEL MEDICAL CENTER   (Israel)

^b Bruce Rappaport School of Medicine   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Cells; Genes; Viruses

Indexed keywords

BROXURIDINE; GENE PRODUCT; IODINE 125; MESSENGER RNA; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; VIRUS VECTOR;

ADENOVIRUS; ANGIOGENESIS; ARTICLE; AUTOCRINE EFFECT; BINDING AFFINITY; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME BINDING; GENE OVEREXPRESSION; GENE TRANSFER; GENETIC CODE; HUMAN; HUMAN CELL; ISOTOPE LABELING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR UPREGULATION; SENSITIZATION; TRANSCRIPTION TERMINATION; VIRUS GENE; VIRUS INFECTION; VIRUS RECOMBINANT;

EID: 0035836581     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.14.1887     Document Type: Article

References (48)

1. Vascular permeability factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine
2. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
3. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
4. Signaling vascular morphogenesis and maintenance
5. Mechanisms of angiogenesis
6. The human gene for vascular endothelial growth factor: Multiple protein forms are encoded through alternative exon splicing
7. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived stellate cells
8. Vascular endothelial growth factor is a secreted angiogenic factor
9. Accelerated endothelialization by local delivery of recombinant human vascular endothelial growth factor reduces in-stent intimal formation
10. 165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
11. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia
12. Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene
13. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb
14. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion
15. 165 as sole therapy for myocardial ischemia
16. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor
17. Use of vascular endothelial growth factor for therapeutic angiogenesis
18. VEGF165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo
19. Therapeutic angiogenesis: A single intraarterial bolus of vascular endothelial growth factor augments revasculatization in a rabbit ischemic hind limb model
20. Vascular gene therapy
21. Angiogenesis by gene therapy: A new horizon for myocardial revascularization?
22. Vascular applications of human gene therapy
23. Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease
24. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
25. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
26. Characterization of the receptors for vascular endothelial growth factor
27. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform specific receptor for vascular endothelial growth factor
28. Glioblastoma growth inhibited in vivo by a dominant negative Flk-1 mutant
29. In vitro neutralization of vascular endothelial growth factor activation of FLK-1 by a monoclonal antibody
30. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells
31. Vascular endothelial growth factor induced by hypoxia-initiated angiogenesis
32. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression
33. Functional upregulation of the endothelial growth factor receptor KDR by hypoxia
34. Characteristics of a human cell line transformed by DNA from human adenovirus type 5
35. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3
36. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5
37. High levels of biologically active vascular endothelial growth factor (VEGF) are produced by the baculovirus expression system
38. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
39. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
40. Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro
41. Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system
42. Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation
43. VEGF121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of chorioallantoic membrane
44. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: Functional competition of collapsin-1 and vascular endothelial growth factor-165
45. Requirement for neuropilin-1 in embryonic vessel formation
46. The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF
47. Selective binding of VEGF121 to one of the three vascular endothelial growth receptors of vascular endothelial cells
48. Therapeutic angiogenesis in ischemic limbs